The Journal of Urology
Volume 184, Issue 3 , Pages 859-864, September 2010

Prospective Clinical Trial of Preoperative Sunitinib in Patients With Renal Cell Carcinoma

  • Nicholas J. Hellenthal

      Affiliations

    • Department of Urology, Roswell Park Cancer Institute, Buffalo, New York
  • ,
  • Willie Underwood

      Affiliations

    • Department of Urology, Roswell Park Cancer Institute, Buffalo, New York
  • ,
  • Remedios Penetrante

      Affiliations

    • Department of Urology, Roswell Park Cancer Institute, Buffalo, New York
  • ,
  • Alan Litwin

      Affiliations

    • Department of Urology, Roswell Park Cancer Institute, Buffalo, New York
  • ,
  • Shaozeng Zhang

      Affiliations

    • Department of Urology, Roswell Park Cancer Institute, Buffalo, New York
  • ,
  • Gregory E. Wilding

      Affiliations

    • Department of Biostatistics, Roswell Park Cancer Institute, Buffalo, New York
  • ,
  • Bin T. Teh

      Affiliations

    • Van Andel Institute, Grand Rapids, Michigan
  • ,
  • Hyung L. Kim

      Affiliations

    • Department of Urology, Roswell Park Cancer Institute, Buffalo, New York
    • Division of Urology, Cedars-Sinai Medical Center, Los Angeles, California
    • Corresponding Author InformationCorrespondence and requests for reprints: Department of Urology, Cedars Sinai Medical Center, 8635 West Third St., Suite 1070 West, Los Angeles, California 90048 (telephone: 310-423-4700; FAX: 310-423-4711)
    • Financial interest and/or other relationship with Pfizer.

Received 12 January 2010 published online 20 July 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supplementary material for this article can be obtained at http://www.csmc.edu/rcc.

 Study received institutional review board approval.

 Supported by Pfizer (HLK) and National Institutes of Health R01CA133072-01.

 For another article on a related topic see page 1166.

PII: S0022-5347(10)03560-3

doi:10.1016/j.juro.2010.05.041

The Journal of Urology
Volume 184, Issue 3 , Pages 859-864, September 2010